1. Étude des facteurs prédictifs de séquelles à 2 ans en lien avec une infection congénitale à Cytomégalovirus
- Author
-
Petermann, Lucile, Université Paris Descartes - Faculté de Médecine (UPD5 Médecine), Université Paris Descartes - Paris 5 (UPD5), and Jean-François Magny
- Subjects
MESH: Cytomegalovirus ,MESH: Immunologic Deficiency Syndromes ,Dépistage sérologique systématique ,MESH: Maternal Serum Screening Tests ,Handicap ,Symptomatic ,Trouble neuro-développemental ,MESH: Prognosis ,Hearing impairment ,Congenital infection ,Infection congénitale ,MESH: Risk Factors ,Pronostic ,MESH: Therapeutics ,Traitement ,MESH: Hearing Loss ,MESH: Neurodevelopmental Disorders ,Facteurs de risques ,MESH: Cytomegalovirus Infections ,MESH: Disabled Persons ,Cytomégalovirus ,Déficience ,Déficience auditive ,Impairment ,Symptomatique ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Objectives: cytomegalovirus (CMV) is the leading cause of congenital infection in the world with a major risk of sequelae including neurological and auditory. The aim of the study is to identify what are the prognostic factors for defining neonates at risk of developing sequelae at 2 years related to congenital CMV infection. Design of the study: monocentric retrospective observational study including 220 patients born between January 2001 and October 2015 with congenital CMV infection. We studied various pre- and postnatal factors and their impact on the outcome at 2 years of age for children with congenital CMV infection. Results: the presence of at least one postnatal abnormality (clinical examination or additional investigations) was a risk factor for developing sequelae at 2 years (p = 0.037). Neonates with maternal seroconversion in the first trimester were more likely to develop sequelae at 2 years (p
- Published
- 2018